Type 2 Diabetes Trial, Recruiting NCT07129148 Sponsor: Second Xiangya Hospital of Central South University Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Type 2 Diabetes Trial, Recruiting

NCT07129148
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have a confirmed diagnosis of Type 2 Diabetes
  • People who are 18 years of age or older
  • People who are willing to use an AI-assisted diabetes management system and wear a health monitoring device
  • People who are able to keep detailed lifestyle records, including medical history, medications, diet, and exercise
  • People who fully understand what the study involves, are willing to take part, agree to a 3-month follow-up period, and sign a consent form

Who may not be able to join:

  • People who have a serious mental illness or significant difficulties with communication or language
  • People who have been diagnosed with a malignant (cancerous) tumour
  • People who are pregnant or currently breastfeeding
  • People who are suspected of having an active infection, such as active tuberculosis or pneumonia
  • People who have severely reduced liver or kidney function, based on specific blood and kidney test results (confirm with trial site)
  • People who have a confirmed history of a major heart or blood vessel event, such as a heart attack or stroke, or who have had procedures to restore blood flow to the heart or brain (confirm with trial site)
  • People who have uncontrolled thyroid conditions, or other hormonal or gland-related disorders that are not well managed
  • People who have a history of alcohol dependence or drug addiction
  • People who are currently receiving insulin therapy
  • People who are unable or unwilling to take part in new technology-based health management approaches, for any reason, including personal beliefs or financial circumstances

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 86-0731-85292223

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Second Xiangya Hospital of Central South University
Registry
ClinicalTrials.gov
Start date
1 October 2025
Est. completion
1 October 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

HbA1c

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov